Niagen Bioscience, Inc. Common Stock (NAGE) is a publicly traded Healthcare sector company. As of October 15, 2026, NAGE trades at $2.59 with a market cap of $204.15M and a P/E ratio of 12.21. NAGE moved +2.37% today. Year to date, NAGE is -59.52%; over the trailing twelve months it is -66.13%. Its 52-week range spans $2.51 to $14.69. Analyst consensus is strong buy with an average price target of $10.50. Rallies surfaces NAGE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for NAGE combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $2.59 |
| Market Cap | $204.15M |
| P/E Ratio | 12.21 |
| EPS | $0.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.69 |
| 52-Week Low | $2.51 |
| Volume | 106.90K |
| Avg Volume | 0 |
| Revenue (TTM) | $129.42M |
| Net Income | $17.38M |
| Gross Margin | 64.28% |
4 analysts cover NAGE: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.50.